Here we identified miR-17~92 family miRNAs as key positive regulators supporting IL-10 production in ATMs, raising possibilities for this family of miRNAs as potential therapeutic targets of inflammatory and metabolic disorders. This evidence concerns the gene IL10 and Other metabolic disease.